PCVX
Vaxcyte Inc
56.50$
+0.8%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +18.9% | +4.9% | +12.5% | +29.1% | +6.5% | +1.9% | +2.4% | +4.2% | +88.6% | -40.3% | +1.6% | – | |
| – | +1.0% | +32.1% | +22.3% | -1.4% | +14.6% | +25.6% | +20.6% | -4.4% | +2.0% | +5.5% | +108.6% | – | |
| – | +12.0% | -294.0% | – | – | -108.5% | – | – | -4.8% | -88.6% | -179.6% | – | – | |
| – | +677.6% | -78.8% | +275.9% | -16.1% | -21.1% | -10.9% | -27.0% | -38.3% | -53.8% | +165.7% | +30.9% | – | |
| – | -162.5% | +3,139.1% | -82.2% | +1,040.5% | -39.2% | – | -37.0% | +55.9% | -5.0% | -302.7% | -63.3% | – | |
| – | – | -159.2% | -82.9% | – | – | – | – | – | – | – | – | – | |
| – | -94.4% | +29,815.8% | -86.5% | +1,272.7% | -99.7% | -84.5% | +231.8% | -245.8% | – | +24,882.7% | +0.9% | – | |
| – | -1,130.4% | – | -143.4% | – | -224.6% | – | – | – | – | – | -89.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.